`
`__________
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`__________
`
`
`
`LUPIN LTD. AND LUPIN PHARMACEUTICALS INC.,
`
`Petitioner
`
`v.
`
`HORIZON THERAPEUTICS, INC.,
`
`Patent Owner
`
`__________
`
`
`
`Case IPR 2016-00829
`
`Patent 9,095,559
`
`__________
`
`
`
`PATENT OWNER’S INITIAL EXHIBIT LIST
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.63(e), the Patent Owner hereby provides an
`
`initial exhibit list:
`
`Exhibit No. Description
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`Complaint for Patent Infringement, Horizon Therapeutics, Inc. v.
`Lupin Ltd. et al., Civil Action No. 15-cv-07624-RBK-JS (D.N.J.
`filed Oct. 19, 2015)
`
`Infringement, Horizon
`for Patent
`Amended Complaint
`Therapeutics, Inc. v. Lupin Ltd. et al., Civil Action No. 15-cv-
`07624-RBK-JS (D.N.J. filed Apr. 6, 2016)
`Simell, “Lysinuric Protein Intolerance and Other Cationic
`Aminoacidurias,” in Scriver et al., (Eds.), The Metabolic &
`Molecular Bases of Inherited Disease, Ch. 192 at 4949 (2001)
`Singh et al., “Nutritional Management of Urea Cycle Disorders,”
`Crit. Care. Clin. 21, S27-35 (2005)
`
`Portion of Invalidity Contentions (pages 16-22), served Nov. 13,
`2014 in Hyperion Therapeutics, Inc. v. Par Pharma., Inc., 2:14-cv-
`00384-JRG-RSP (E.D. Tex.)
`
`Respectfully submitted,
`
`Date: 2016 July 7
`
`
`
`
`
`By: / M.C. Phillips /
`Matthew C. Phillips
`Reg. No. 43,403
`Backup Counsel for Patent Owner
`
`
`IPR2016-00829
`
`
`
`1
`
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on July 7, 2016, a copy of the foregoing PATENT
`
`OWNER’S INITIAL EXHIBIT LIST and all documents filed with it were
`
`served was served via electronic mail, as agreed to by counsel, upon the following
`
`counsel for the Petitioners:
`
`Elizabeth J. Holland: eholland@goodwinproctor.com
`
`Cynthia Lambert Hardman: chardman@goodwinprocter.com
`
`/ M.C. Phillips /
`Matthew C. Phillips
`Reg. No. 43,403
`Backup Counsel for Patent Owner
`
`
`
`
`
`IPR2016-00829
`
`
`
`2